March 18 (Reuters) - Madrigal Pharmaceuticals ( MDGL )
said on Monday it has commenced an underwritten public offering
of $500 million in shares of its common stock and pre-funded
warrants to purchase common stock.
(Reporting by Mariam Sunny in Bengaluru)